Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial.

Fennell, Dean A; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela

Fennell, Dean A; Porter, Catharine; Lester, Jason; Danson, Sarah; Taylor, Paul; Sheaff, Michael; Rudd, Robin M; Gaba, Aarti; Busacca, Sara; Nixon, Lisette; Gardner, Georgina; Darlison, Liz; Poile, Charlotte; Richards, Cathy; Jordan, Peter-Wells; Griffiths, Gareth; Casbard, Angela.

Afiliação

Fennell DA; Mesothelioma Research Programme, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester LE2 7LX, UK.
Porter C; University Hospitals of Leicester NHS Trust, Leicester, UK.
Lester J; Centre for Trials Research, Cardiff University, Wales, UK.
Danson S; The Rutherford Cancer Centre, Newport, UK.
Taylor P; Sheffield ECMC, University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.
Sheaff M; Department of Medical Oncology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Rudd RM; Barts Health NHS Trust, London, UK.
Gaba A; The London Clinic, London, UK.
Busacca S; Mesothelioma Research Programme, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester LE2 7LX, UK.
Nixon L; Mesothelioma Research Programme, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester LE2 7LX, UK.
Gardner G; Centre for Trials Research, Cardiff University, Wales, UK.
Darlison L; Centre for Trials Research, Cardiff University, Wales, UK.
Poile C; University Hospitals of Leicester NHS Trust, Leicester, UK.
Richards C; Mesothelioma Research Programme, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester LE2 7LX, UK.
Jordan PW; University Hospitals of Leicester NHS Trust, Leicester, UK.
Griffiths G; Mesothelioma Research Programme, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester LE2 7LX, UK.
Casbard A; CRUK Southampton Clinical Trials Unit, University of, Southampton, Southampton, UK.

EClinicalMedicine ; 48: 101432, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35706488

Palavras-chave

BRCA1; Mesothelioma; Pleural; Randomised; Relapsed; Vinorelbine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Revista: EClinicalMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google